» Articles » PMID: 34367505

Effect of Trabeculated Myocardial Mass on Left Ventricle Global and Regional Functions in Noncompaction Cardiomyopathy

Overview
Journal World J Cardiol
Date 2021 Aug 9
PMID 34367505
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Left ventricular (LV) noncompaction cardiomyopathy is a rare cardiomyopathic subtype that has been recognized in recent years and is being diagnosed at an increased rate. There is no consensus regarding the diagnosis of the disease, and increased trabeculation rates that meet the existing diagnostic criteria may even be present in healthy asymptomatic people. This indicates that differentiating criteria for diagnosis are needed.

Aim: To examine the increase in myocardial trabeculation and the change in left ventricular global and regional functions.

Methods: This retrospective study included 65 patients (28 females, 37 males) diagnosed with LV noncompaction cardiomyopathy who underwent cardiac magnetic resonance imaging between January 2011 and August 2016 and had a noncompacted/compacted myocardial thickness ratio of over 2.3 in more than one segment in the left ventricle. The distribution and ratios of trabeculations in apical, midventricular, and basal regions were examined in short-axis images obtained from cardiac magnetic resonance. In addition, by using short-axis cine images, regional ejection fraction (EF) and global EF were calculated using the Simpson method in the left ventricle at apical, basal, and midventricular levels.

Results: While the number of trabeculated segments were similar at the apical (3.2 ± 1.0) and midventricular levels, a statistically significant level of involvement was not observed at the basal level (0.4 ± 0.9) ( > 0.05). The highest noncompacted/compacted (trabeculation) ratio was observed at the apical level (3.9 ± 1.4), while this ratio was higher at the anterior (59%-89.4%) and lateral (62%-84.8%) segments ( > 0.05). Global EF was positively correlated with apical, midventricular, and basal regional EF ( < 0.05). However, there was no significant correlation between regional EF and the number of trabeculated segments or trabeculation ratio in all three regions; nor was there a significant correlation between regional EF and the number of trabeculated segments or trabeculation ratio in the entire LV ( > 0.05).

Conclusion: No global or regional relationship was observed between LV dysfunction and trabeculation rate or the number of trabeculated segments. This limits the usefulness of change in LV functions in the differentiation between normal and pathological trabeculation.

Citing Articles

Left ventricular function assessment including or excluding trabeculations in left ventricular non-compaction, a preliminary case-control cardiac magnetic resonance study.

Laissy J, Ben Driss A Quant Imaging Med Surg. 2024; 14(3):2475-2484.

PMID: 38545080 PMC: 10963818. DOI: 10.21037/qims-23-1274.

References
1.
Arbustini E, Weidemann F, Hall J . Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?. J Am Coll Cardiol. 2014; 64(17):1840-50. PMC: 10352990. DOI: 10.1016/j.jacc.2014.08.030. View

2.
Tariq M, Ware S . Importance of genetic evaluation and testing in pediatric cardiomyopathy. World J Cardiol. 2014; 6(11):1156-65. PMC: 4244613. DOI: 10.4330/wjc.v6.i11.1156. View

3.
Petersen S, Selvanayagam J, Wiesmann F, Robson M, Francis J, Anderson R . Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005; 46(1):101-5. DOI: 10.1016/j.jacc.2005.03.045. View

4.
Grothoff M, Pachowsky M, Hoffmann J, Posch M, Klaassen S, Lehmkuhl L . Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol. 2012; 22(12):2699-709. PMC: 3486997. DOI: 10.1007/s00330-012-2554-7. View

5.
Mavrogeni S, Markousis-Mavrogenis G, Vartela V, Manolopoulou D, Abate E, Hamadanchi A . The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients. Heart Fail Rev. 2019; 25(6):1007-1015. DOI: 10.1007/s10741-019-09898-8. View